Cargando…
Long COVID in a prospective cohort of home-isolated patients
Long-term complications after coronavirus disease 2019 (COVID-19) are common in hospitalized patients, but the spectrum of symptoms in milder cases needs further investigation. We conducted a long-term follow-up in a prospective cohort study of 312 patients—247 home-isolated and 65 hospitalized—comp...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8440190/ https://www.ncbi.nlm.nih.gov/pubmed/34163090 http://dx.doi.org/10.1038/s41591-021-01433-3 |
_version_ | 1783752659446005760 |
---|---|
author | Blomberg, Bjørn Mohn, Kristin Greve-Isdahl Brokstad, Karl Albert Zhou, Fan Linchausen, Dagrun Waag Hansen, Bent-Are Lartey, Sarah Onyango, Therese Bredholt Kuwelker, Kanika Sævik, Marianne Bartsch, Hauke Tøndel, Camilla Kittang, Bård Reiakvam Cox, Rebecca Jane Langeland, Nina |
author_facet | Blomberg, Bjørn Mohn, Kristin Greve-Isdahl Brokstad, Karl Albert Zhou, Fan Linchausen, Dagrun Waag Hansen, Bent-Are Lartey, Sarah Onyango, Therese Bredholt Kuwelker, Kanika Sævik, Marianne Bartsch, Hauke Tøndel, Camilla Kittang, Bård Reiakvam Cox, Rebecca Jane Langeland, Nina |
author_sort | Blomberg, Bjørn |
collection | PubMed |
description | Long-term complications after coronavirus disease 2019 (COVID-19) are common in hospitalized patients, but the spectrum of symptoms in milder cases needs further investigation. We conducted a long-term follow-up in a prospective cohort study of 312 patients—247 home-isolated and 65 hospitalized—comprising 82% of total cases in Bergen during the first pandemic wave in Norway. At 6 months, 61% (189/312) of all patients had persistent symptoms, which were independently associated with severity of initial illness, increased convalescent antibody titers and pre-existing chronic lung disease. We found that 52% (32/61) of home-isolated young adults, aged 16–30 years, had symptoms at 6 months, including loss of taste and/or smell (28%, 17/61), fatigue (21%, 13/61), dyspnea (13%, 8/61), impaired concentration (13%, 8/61) and memory problems (11%, 7/61). Our findings that young, home-isolated adults with mild COVID-19 are at risk of long-lasting dyspnea and cognitive symptoms highlight the importance of infection control measures, such as vaccination. |
format | Online Article Text |
id | pubmed-8440190 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Nature Publishing Group US |
record_format | MEDLINE/PubMed |
spelling | pubmed-84401902021-09-22 Long COVID in a prospective cohort of home-isolated patients Blomberg, Bjørn Mohn, Kristin Greve-Isdahl Brokstad, Karl Albert Zhou, Fan Linchausen, Dagrun Waag Hansen, Bent-Are Lartey, Sarah Onyango, Therese Bredholt Kuwelker, Kanika Sævik, Marianne Bartsch, Hauke Tøndel, Camilla Kittang, Bård Reiakvam Cox, Rebecca Jane Langeland, Nina Nat Med Article Long-term complications after coronavirus disease 2019 (COVID-19) are common in hospitalized patients, but the spectrum of symptoms in milder cases needs further investigation. We conducted a long-term follow-up in a prospective cohort study of 312 patients—247 home-isolated and 65 hospitalized—comprising 82% of total cases in Bergen during the first pandemic wave in Norway. At 6 months, 61% (189/312) of all patients had persistent symptoms, which were independently associated with severity of initial illness, increased convalescent antibody titers and pre-existing chronic lung disease. We found that 52% (32/61) of home-isolated young adults, aged 16–30 years, had symptoms at 6 months, including loss of taste and/or smell (28%, 17/61), fatigue (21%, 13/61), dyspnea (13%, 8/61), impaired concentration (13%, 8/61) and memory problems (11%, 7/61). Our findings that young, home-isolated adults with mild COVID-19 are at risk of long-lasting dyspnea and cognitive symptoms highlight the importance of infection control measures, such as vaccination. Nature Publishing Group US 2021-06-23 2021 /pmc/articles/PMC8440190/ /pubmed/34163090 http://dx.doi.org/10.1038/s41591-021-01433-3 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Blomberg, Bjørn Mohn, Kristin Greve-Isdahl Brokstad, Karl Albert Zhou, Fan Linchausen, Dagrun Waag Hansen, Bent-Are Lartey, Sarah Onyango, Therese Bredholt Kuwelker, Kanika Sævik, Marianne Bartsch, Hauke Tøndel, Camilla Kittang, Bård Reiakvam Cox, Rebecca Jane Langeland, Nina Long COVID in a prospective cohort of home-isolated patients |
title | Long COVID in a prospective cohort of home-isolated patients |
title_full | Long COVID in a prospective cohort of home-isolated patients |
title_fullStr | Long COVID in a prospective cohort of home-isolated patients |
title_full_unstemmed | Long COVID in a prospective cohort of home-isolated patients |
title_short | Long COVID in a prospective cohort of home-isolated patients |
title_sort | long covid in a prospective cohort of home-isolated patients |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8440190/ https://www.ncbi.nlm.nih.gov/pubmed/34163090 http://dx.doi.org/10.1038/s41591-021-01433-3 |
work_keys_str_mv | AT blombergbjørn longcovidinaprospectivecohortofhomeisolatedpatients AT mohnkristingreveisdahl longcovidinaprospectivecohortofhomeisolatedpatients AT brokstadkarlalbert longcovidinaprospectivecohortofhomeisolatedpatients AT zhoufan longcovidinaprospectivecohortofhomeisolatedpatients AT linchausendagrunwaag longcovidinaprospectivecohortofhomeisolatedpatients AT hansenbentare longcovidinaprospectivecohortofhomeisolatedpatients AT larteysarah longcovidinaprospectivecohortofhomeisolatedpatients AT onyangotheresebredholt longcovidinaprospectivecohortofhomeisolatedpatients AT kuwelkerkanika longcovidinaprospectivecohortofhomeisolatedpatients AT sævikmarianne longcovidinaprospectivecohortofhomeisolatedpatients AT bartschhauke longcovidinaprospectivecohortofhomeisolatedpatients AT tøndelcamilla longcovidinaprospectivecohortofhomeisolatedpatients AT kittangbardreiakvam longcovidinaprospectivecohortofhomeisolatedpatients AT longcovidinaprospectivecohortofhomeisolatedpatients AT coxrebeccajane longcovidinaprospectivecohortofhomeisolatedpatients AT langelandnina longcovidinaprospectivecohortofhomeisolatedpatients |